Nifedipine Dosing for Prevention of Preterm Labor

Administration Considerations

Nifedipine should be administered orally, not sublingually, as sublingual administration increases the risk of sudden hypotension in pregnant patients 1

Maternal blood pressure should be monitored closely, especially during the first hour of treatment, to minimize the risk of hypotension in pregnant patients 1

Nifedipine should be used with caution when combined with magnesium sulfate due to the risk of precipitous blood pressure drop in pregnant patients 1, 2
Common side effects of nifedipine include dizziness, headache, and flushing, which occur in a significant proportion of pregnant patients 1

Nifedipine is not FDA-approved specifically for preterm labor management but is used off-label for this indication in pregnant patients 1
For hypertensive emergencies in pregnancy, a different dosing regimen of nifedipine is used, with 10-20 mg of short-acting nifedipine and possible repeat in 30 minutes if needed, as recommended by the European Heart Journal 2, 3
The goal of tocolysis with nifedipine is to allow time for administration of corticosteroids for fetal lung maturity, especially in pregnancies ≤34 weeks gestation, as stated by the European Heart Journal 4

The maximum daily dose of nifedipine for preterm labor is 120 mg daily or 60 mg twice daily, as recommended by the American Heart Association, based on evidence from the American College of Cardiology 5, 6

Nifedipine is contraindicated in heart failure, according to the American College of Cardiology 5, 6
The titration interval for nifedipine in stable patients is typically 5-7 days, as suggested by the American Heart Association 5, 6

The American College of Obstetricians and Gynecologists recommends tocolysis at 33 weeks gestation to allow for the administration of corticosteroids for fetal lung maturation, especially if not previously administered, and to gain time for transfer to a center with a neonatal intensive care unit if necessary 7
Tocolysis is justified to improve outcomes, despite limited evidence on its efficacy, as it allows for interventions that do improve outcomes, such as corticosteroids and magnesium sulfate for neuroprotection 7

A study compared high-dose versus low-dose nifedipine regimens, with the high-dose regimen resulting in less need for rescue treatment and better gestational age at birth, although with no differences in uterine quieting at 48 hours 7